When you drink green tea, your liver uses a special enzyme called COMT to change two of its key compounds—EGCG and EGC—into slightly different forms, and scientists have seen this happen in test tubes using liver fluid from humans, mice, and rats.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim describes a specific biochemical reaction observed in controlled in vitro experiments using liver cytosol, which is a standard method to demonstrate direct enzyme-substrate relationships. The use of 'are methylated' and 'producing' is appropriate because the study directly observes the enzymatic conversion in a purified system. No overstatement occurs because the claim is limited to in vitro conditions and does not extrapolate to in vivo effects or health outcomes.
Context Details
Domain
nutrition
Population
in_vitro
Subject
(-)-Epigallocatechin gallate (EGCG) and (-)-epigallocatechin (EGC)
Action
are methylated by
Target
catechol-O-methyltransferase (COMT) in human, mouse, and rat liver cytosol, producing 4"-O-methyl-EGCG, 4',4"-di-O-methyl-EGCG, and 4'-O-methyl-EGC
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate.
The study showed that the green tea chemicals EGCG and EGC get changed by a liver enzyme called COMT in humans, mice, and rats — exactly what the claim says.